Tüdőrák: vizsgálatok itt: Kína
1144 trials · From ClinicalTrials.gov, checked 2026. november 16.. Ask the study team whether a trial fits you.
- 2. fázisTaking peopleHC010 in First-line PD-L1 Positive Advanced NSCLC Patients
- Where
- Shanghai
- Életkor
- 18 év and over
- People
- 50
- Run by
- HC Biopharma Inc.
See details and how to joinNCT07169552 - No phaseNot yet taking people in KínaPrediction of Targeted Therapy Efficacy in EGFR-mutant Lung Cancer Patients Using AI-based Multimodal Data
- Where
- Wuhan
- Életkor
- 18 év to 80 év
- People
- 1000
- Run by
- Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
See details and how to joinNCT07287904 - 2. fázisNot yet taking people in KínaStereotactic Body Radiotherapy With Sequential Iparomlimab and Tuvonralimab (QL1706) + Chemotherapy as Neoadjuvant Therapy in Patients With Resectable Non-small-cell Lung Cancer in China (LUNG-Nanjing01): a Single-arm, Single-centre, Phase 2 Trial
- Where
- Nanjing
- Életkor
- 18 év to 75 év
- People
- 24
- Run by
- Jiangsu Cancer Institute & Hospital
See details and how to joinNCT07286942 - 3. fázisTaking peopleA Phase 3 Study of Sunvozertinib Versus Placebo as Adjuvant Therapy in Patients With Early-Stage Non-Small Cell Lung Cancer Harboring EGFR Exon 20 Insertion Mutations or PACC Mutations After Radical Surgery
- Where
- Beijing, Changchun, Changsha, Chengdu, Fuzhou, Guangzhou, Hangzhou, Harbin, Hefei, Jinan, Kunming, Nanchang, Nanjing, Nanning, Shanghai, Shenyang, Taiyuan, Taizhou, Tianjin, Wuhan, Xi’an, Xuzhou, Zhengzhou
- Életkor
- 18 év and over
- People
- 360
- Run by
- Dizal (Jiangsu) Pharmaceutical Co., Ltd.
See details and how to joinNCT07182682 - 2. fázisTaking peopleA Trial of HRS-4508 Combined With Other Antitumor Therapies in Subjects With Locally Advanced or Metastatic Non-small Cell Lung Cancer
- Where
- Hangzhou, Shanghai
- Életkor
- 18 év to 75 év
- People
- 100
- Run by
- Jiangsu HengRui Medicine Co., Ltd.
See details and how to joinNCT07232849 - 1. fázisTaking peopleA Study of GC203 TIL in Advanced Malignant Solid Tumors
- Where
- Shanghai
- Életkor
- 18 év to 75 év
- People
- 18
- Run by
- Shanghai Juncell Therapeutics
See details and how to joinNCT06375187 - No phaseNot yet taking people in KínaThe Percutaneous Interventional Surgery Control System for Pulmonary Nodule Biopsy
- Where
- Shanghai
- Életkor
- 18 év to 80 év
- People
- 158
- Run by
- Jiayuan Sun
See details and how to joinNCT07277088 - 1/2. fázisTaking peopleLK101 Combined With PD-1 or PD-L1 Monoclonal Antibody in the Treatment of Lung Cancer
- Where
- Beijing
- Életkor
- 18 év and over
- People
- 60
- Run by
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences
See details and how to joinNCT05886439 - 2. fázisTaking peoplePost-line Treatment With Teniposide for c-Myc-driven Extensive-stage Small Cell Lung Cancer
- Where
- Shanghai
- Életkor
- 18 év to 75 év
- People
- 15
- Run by
- Shanghai Pulmonary Hospital, Shanghai, China
See details and how to joinNCT06758700 - 1/2. fázisTaking peopleEvaluate the Safety, Tolerability, Biodistribution Characteristics and Preliminary Efficacy of BioTTT001
- Where
- Zhengzhou
- Életkor
- 18 év to 70 év
- People
- 42
- Run by
- Henan Cancer Hospital
See details and how to joinNCT07264569 - 1/2. fázisTaking peopleStudy of GV20-0251 in Participants With Solid Tumor Malignancies
- Where
- Beijing, Shanghai
- Életkor
- 18 év and over
- People
- 350
- Run by
- GV20 Therapeutics
See details and how to joinNCT07070518 - 1. fázisTaking peopleVSV-02 Compassionate Use in Advanced Solid Tumors
- Where
- Xinxiang
- Életkor
- 18 év and over
- People
- 6
- Run by
- The First Affiliated Hospital of Xinxiang Medical College
See details and how to joinNCT07260591 - 2. fázisTaking peoplePhase II Clinical Study of Pyrotinib in First-line Treatment of Primary HER2-amplified/Mutated Advanced Non-small Cell Lung Cancer
- Where
- Beijing
- Életkor
- 18 év and over
- People
- 18
- Run by
- Peking Union Medical College Hospital
See details and how to joinNCT05751018 - 1/2. fázisTaking peopleEvaluating the Safety, Tolerability, and Preliminary Anti-tumor Activity of MB0151 in Adult Subjects With Advanced Solid Tumors Expressing Somatostatin Receptors
- Where
- Jinan
- Életkor
- 18 év and over
- People
- 156
- Run by
- Mainline Biosciences (Shanghai) Co., Ltd
See details and how to joinNCT06840821 - No phaseTaking peopleRAPART in Locally Advanced Non-small Cell Lung Cancer Patients
- Where
- Shenzhen
- Életkor
- 18 év and over
- People
- 911
- Run by
- Capital Medical University
See details and how to joinNCT07164885 - No phaseTaking peopleApplication of Methylation Markers in Early Detection and MRD Monitoring of Lung Cancer
- Where
- Beijing
- Életkor
- 18 év to 85 év
- People
- 30
- Run by
- Beijing Haidian Hospital
See details and how to joinNCT07257458 - No phaseTaking peopleApplication Research of Methylation Markers in Early-stage Lung Cancer Patients Treated With Co-ablation System Therapy
- Where
- Beijing
- Életkor
- 18 év to 85 év
- People
- 30
- Run by
- Beijing Haidian Hospital
See details and how to joinNCT07257471 - 2. fázisTaking peopleA Study of SHR-A2102 in Combination With Other Anti-tumor Therapies for Resectable Non-small Cell Lung Cancer
- Where
- Guangzhou
- Életkor
- 18 év to 70 év
- People
- 300
- Run by
- Shanghai Hengrui Pharmaceutical Co., Ltd.
See details and how to joinNCT07229729 - No phaseTaking peopleThe Effectiveness and Safety of SBRT in the Treatment of Patients With MPLC After Surgery (SMILE)
- Where
- Changsha, Wuhan
- Életkor
- 18 év to 75 év
- People
- 40
- Run by
- Fang Wu
See details and how to joinNCT05113017 - 2. fázisTaking peopleA Study of Osimertinib-based Adaptive Treatment Guided by ctDNA EGFRm+ Monitoring in NSCLC
- Where
- Shanghai
- Életkor
- 18 év and over
- People
- 250
- Run by
- Shanghai Chest Hospital
See details and how to joinNCT07058519 - 1. fázisTaking peopleA Study of CEA-Targeted CAR-T Therapy in Patients With CEA-Positive Advanced Solid Tumors
- Where
- Hangzhou
- Életkor
- 18 év and over
- People
- 48
- Run by
- Second Affiliated Hospital, Zhejiang University, School of Medicine
See details and how to joinNCT07250386 - No phaseTaking peopleReal-world First-line Sugemalimab-Chemotherapy in Advanced NSCLC
- Where
- Beijing
- Életkor
- 18 év and over
- People
- 150
- Run by
- Peking Union Medical College
See details and how to joinNCT07247227 - No phaseTaking peopleStudy on the Diagnosis of Ground-glass Lung Cancer by Microwave Ablation Combined With Puncture Biopsy
- Where
- Harbin
- Életkor
- 18 év to 75 év
- People
- 200
- Run by
- Beidahuang Industry Group General Hospital
See details and how to joinNCT06776588 - 1. fázisTaking peopleA Study of GV20-0251 in Advanced or Refractory Solid Tumors
- Where
- Chengdu
- Életkor
- 18 év and over
- People
- 10
- Run by
- West China Hospital
See details and how to joinNCT07106827 - 1. fázisTaking peopleA Study of BL-M24D1 in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer and Other Solid Tumors
- Where
- Guangzhou
- Életkor
- 18 év and over
- People
- 33
- Run by
- Sichuan Baili Pharmaceutical Co., Ltd.
See details and how to joinNCT07232420